(Oxford, UK and Philadelphia, USA, 21 May 2018) Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, is pleased to note that the Company was the winner of the 2018 Vale4Business (V4B) Award for Large Business of the Year.
The V4B Awards aim to bring together the achievements of businesses in the area; recognising, rewarding and promoting local success stories.
Andrew Hotchkiss, Chief Executive Officer of Immunocore, said: “We are delighted to have been presented with this award, which reflects the great progress we have made in growing our business but also developing our ImmTAC (Immune mobilising monoclonal TCRs Against Cancer) technology. We’re particularly pleased to have been chosen among such strong competition in this region, which is such a great hub for dynamic businesses like Immunocore. The unique combination of factors which have helped nurture so many businesses in the Oxford region have played a key role in Immunocore’s success and we’re proud to be a standard-bearer for the area.
“I would like to thank the rest of the team at Immunocore for their invaluable hard work, commitment and support.”
Please click on the link below to download the full Press Release: